 | • レポートコード：MRC2Q12-19170 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、ラシジピンのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 ラシジピンのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ラシジピンの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ラシジピンのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのラシジピンの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のラシジピンの売上および2028年までの予測に焦点を当てています。 ラシジピンのグローバル主要企業には、Dr. Reddy's Laboratories (UK)、Rivopharm、Pliva、West Coast、GSK、Creo Pharma、NIKSAN HEALTHCARE、Dideu Group、Incepta Pharmaceuticals、Synmosa Biopharma、Square Pharmaceuticals、Harbin Pharmaceutical Group、Zhejiang Better Pharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ラシジピン市場は、タイプとアプリケーションによって区分されます。世界のラシジピン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 2mg、4mg、6mg 【アプリケーション別セグメント】 オンライン薬局、オフライン薬局 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ラシジピン製品概要 - タイプ別市場（2mg、4mg、6mg） - アプリケーション別市場（オンライン薬局、オフライン薬局） - 調査の目的 ・エグゼクティブサマリー - 世界のラシジピン販売量予測2017-2028 - 世界のラシジピン売上予測2017-2028 - ラシジピンの地域別販売量 - ラシジピンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ラシジピン販売量 - 主要メーカー別ラシジピン売上 - 主要メーカー別ラシジピン価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（2mg、4mg、6mg） - ラシジピンのタイプ別販売量 - ラシジピンのタイプ別売上 - ラシジピンのタイプ別価格 ・アプリケーション別市場規模（オンライン薬局、オフライン薬局） - ラシジピンのアプリケーション別販売量 - ラシジピンのアプリケーション別売上 - ラシジピンのアプリケーション別価格 ・北米市場 - 北米のラシジピン市場規模（タイプ別、アプリケーション別） - 主要国別のラシジピン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのラシジピン市場規模（タイプ別、アプリケーション別） - 主要国別のラシジピン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のラシジピン市場規模（タイプ別、アプリケーション別） - 主要国別のラシジピン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のラシジピン市場規模（タイプ別、アプリケーション別） - 主要国別のラシジピン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのラシジピン市場規模（タイプ別、アプリケーション別） - 主要国別のラシジピン市場規模（トルコ、サウジアラビア） ・企業情報 Dr. Reddy's Laboratories (UK)、Rivopharm、Pliva、West Coast、GSK、Creo Pharma、NIKSAN HEALTHCARE、Dideu Group、Incepta Pharmaceuticals、Synmosa Biopharma、Square Pharmaceuticals、Harbin Pharmaceutical Group、Zhejiang Better Pharmaceuticals ・産業チェーン及び販売チャネル分析 - ラシジピンの産業チェーン分析 - ラシジピンの原材料 - ラシジピンの生産プロセス - ラシジピンの販売及びマーケティング - ラシジピンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ラシジピンの産業動向 - ラシジピンのマーケットドライバー - ラシジピンの課題 - ラシジピンの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Lacidipine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Lacidipine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Lacidipine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Lacidipine include Dr. Reddy’s Laboratories (UK), Rivopharm, Pliva, West Coast, GSK, Creo Pharma, NIKSAN HEALTHCARE, Dideu Group and Incepta Pharmaceuticals, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Lacidipine manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Lacidipine market. Further, it explains the major drivers and regional dynamics of the global Lacidipine market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Dr. Reddy’s Laboratories (UK)
Rivopharm
Pliva
West Coast
GSK
Creo Pharma
NIKSAN HEALTHCARE
Dideu Group
Incepta Pharmaceuticals
Synmosa Biopharma
Square Pharmaceuticals
Harbin Pharmaceutical Group
Zhejiang Better Pharmaceuticals
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Lacidipine Segment by Type
2 mg
4 mg
6 mg
Lacidipine Segment by Application
Online Pharmacy
Offline Pharmacy
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Lacidipine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Lacidipine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Lacidipine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Lacidipine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Lacidipine sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Lacidipine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Lacidipine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Dr. Reddy’s Laboratories (UK), Rivopharm, Pliva, West Coast, GSK, Creo Pharma, NIKSAN HEALTHCARE, Dideu Group and Incepta Pharmaceuticals, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Lacidipine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Lacidipine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lacidipine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Lacidipine Product Introduction
1.2 Market by Type
1.2.1 Global Lacidipine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 2 mg
1.2.3 4 mg
1.2.4 6 mg
1.3 Market by Application
1.3.1 Global Lacidipine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Online Pharmacy
1.3.3 Offline Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Lacidipine Sales Estimates and Forecasts 2017-2028
2.2 Global Lacidipine Revenue Estimates and Forecasts 2017-2028
2.3 Global Lacidipine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Lacidipine Sales by Region
2.4.1 Global Lacidipine Sales by Region (2017-2022)
2.4.2 Global Sales Lacidipine by Region (2023-2028)
2.5 Global Lacidipine Revenue by Region
2.5.1 Global Lacidipine Revenue by Region (2017-2022)
2.5.2 Global Lacidipine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Lacidipine Sales by Manufacturers
3.1.1 Global Top Lacidipine Manufacturers by Sales (2017-2022)
3.1.2 Global Lacidipine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Lacidipine in 2021
3.2 Global Lacidipine Revenue by Manufacturers
3.2.1 Global Lacidipine Revenue by Manufacturers (2017-2022)
3.2.2 Global Lacidipine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Lacidipine Revenue in 2021
3.3 Global Lacidipine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Lacidipine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Lacidipine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Lacidipine Sales by Type
4.1.1 Global Lacidipine Historical Sales by Type (2017-2022)
4.1.2 Global Lacidipine Forecasted Sales by Type (2023-2028)
4.1.3 Global Lacidipine Sales Market Share by Type (2017-2028)
4.2 Global Lacidipine Revenue by Type
4.2.1 Global Lacidipine Historical Revenue by Type (2017-2022)
4.2.2 Global Lacidipine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Lacidipine Revenue Market Share by Type (2017-2028)
4.3 Global Lacidipine Price by Type
4.3.1 Global Lacidipine Price by Type (2017-2022)
4.3.2 Global Lacidipine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Lacidipine Sales by Application
5.1.1 Global Lacidipine Historical Sales by Application (2017-2022)
5.1.2 Global Lacidipine Forecasted Sales by Application (2023-2028)
5.1.3 Global Lacidipine Sales Market Share by Application (2017-2028)
5.2 Global Lacidipine Revenue by Application
5.2.1 Global Lacidipine Historical Revenue by Application (2017-2022)
5.2.2 Global Lacidipine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Lacidipine Revenue Market Share by Application (2017-2028)
5.3 Global Lacidipine Price by Application
5.3.1 Global Lacidipine Price by Application (2017-2022)
5.3.2 Global Lacidipine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Lacidipine Market Size by Type
6.1.1 North America Lacidipine Sales by Type (2017-2028)
6.1.2 North America Lacidipine Revenue by Type (2017-2028)
6.2 North America Lacidipine Market Size by Application
6.2.1 North America Lacidipine Sales by Application (2017-2028)
6.2.2 North America Lacidipine Revenue by Application (2017-2028)
6.3 North America Lacidipine Market Size by Country
6.3.1 North America Lacidipine Sales by Country (2017-2028)
6.3.2 North America Lacidipine Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Lacidipine Market Size by Type
7.1.1 Europe Lacidipine Sales by Type (2017-2028)
7.1.2 Europe Lacidipine Revenue by Type (2017-2028)
7.2 Europe Lacidipine Market Size by Application
7.2.1 Europe Lacidipine Sales by Application (2017-2028)
7.2.2 Europe Lacidipine Revenue by Application (2017-2028)
7.3 Europe Lacidipine Market Size by Country
7.3.1 Europe Lacidipine Sales by Country (2017-2028)
7.3.2 Europe Lacidipine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Lacidipine Market Size by Type
8.1.1 Asia Pacific Lacidipine Sales by Type (2017-2028)
8.1.2 Asia Pacific Lacidipine Revenue by Type (2017-2028)
8.2 Asia Pacific Lacidipine Market Size by Application
8.2.1 Asia Pacific Lacidipine Sales by Application (2017-2028)
8.2.2 Asia Pacific Lacidipine Revenue by Application (2017-2028)
8.3 Asia Pacific Lacidipine Market Size by Region
8.3.1 Asia Pacific Lacidipine Sales by Region (2017-2028)
8.3.2 Asia Pacific Lacidipine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Lacidipine Market Size by Type
9.1.1 Latin America Lacidipine Sales by Type (2017-2028)
9.1.2 Latin America Lacidipine Revenue by Type (2017-2028)
9.2 Latin America Lacidipine Market Size by Application
9.2.1 Latin America Lacidipine Sales by Application (2017-2028)
9.2.2 Latin America Lacidipine Revenue by Application (2017-2028)
9.3 Latin America Lacidipine Market Size by Country
9.3.1 Latin America Lacidipine Sales by Country (2017-2028)
9.3.2 Latin America Lacidipine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Lacidipine Market Size by Type
10.1.1 Middle East and Africa Lacidipine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Lacidipine Revenue by Type (2017-2028)
10.2 Middle East and Africa Lacidipine Market Size by Application
10.2.1 Middle East and Africa Lacidipine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Lacidipine Revenue by Application (2017-2028)
10.3 Middle East and Africa Lacidipine Market Size by Country
10.3.1 Middle East and Africa Lacidipine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Lacidipine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Dr. Reddy’s Laboratories (UK)
11.1.1 Dr. Reddy’s Laboratories (UK) Corporation Information
11.1.2 Dr. Reddy’s Laboratories (UK) Overview
11.1.3 Dr. Reddy’s Laboratories (UK) Lacidipine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Dr. Reddy’s Laboratories (UK) Lacidipine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Dr. Reddy’s Laboratories (UK) Recent Developments
11.2 Rivopharm
11.2.1 Rivopharm Corporation Information
11.2.2 Rivopharm Overview
11.2.3 Rivopharm Lacidipine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Rivopharm Lacidipine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Rivopharm Recent Developments
11.3 Pliva
11.3.1 Pliva Corporation Information
11.3.2 Pliva Overview
11.3.3 Pliva Lacidipine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Pliva Lacidipine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pliva Recent Developments
11.4 West Coast
11.4.1 West Coast Corporation Information
11.4.2 West Coast Overview
11.4.3 West Coast Lacidipine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 West Coast Lacidipine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 West Coast Recent Developments
11.5 GSK
11.5.1 GSK Corporation Information
11.5.2 GSK Overview
11.5.3 GSK Lacidipine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GSK Lacidipine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GSK Recent Developments
11.6 Creo Pharma
11.6.1 Creo Pharma Corporation Information
11.6.2 Creo Pharma Overview
11.6.3 Creo Pharma Lacidipine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Creo Pharma Lacidipine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Creo Pharma Recent Developments
11.7 NIKSAN HEALTHCARE
11.7.1 NIKSAN HEALTHCARE Corporation Information
11.7.2 NIKSAN HEALTHCARE Overview
11.7.3 NIKSAN HEALTHCARE Lacidipine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 NIKSAN HEALTHCARE Lacidipine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 NIKSAN HEALTHCARE Recent Developments
11.8 Dideu Group
11.8.1 Dideu Group Corporation Information
11.8.2 Dideu Group Overview
11.8.3 Dideu Group Lacidipine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Dideu Group Lacidipine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Dideu Group Recent Developments
11.9 Incepta Pharmaceuticals
11.9.1 Incepta Pharmaceuticals Corporation Information
11.9.2 Incepta Pharmaceuticals Overview
11.9.3 Incepta Pharmaceuticals Lacidipine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Incepta Pharmaceuticals Lacidipine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Incepta Pharmaceuticals Recent Developments
11.10 Synmosa Biopharma
11.10.1 Synmosa Biopharma Corporation Information
11.10.2 Synmosa Biopharma Overview
11.10.3 Synmosa Biopharma Lacidipine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Synmosa Biopharma Lacidipine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Synmosa Biopharma Recent Developments
11.11 Square Pharmaceuticals
11.11.1 Square Pharmaceuticals Corporation Information
11.11.2 Square Pharmaceuticals Overview
11.11.3 Square Pharmaceuticals Lacidipine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Square Pharmaceuticals Lacidipine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Square Pharmaceuticals Recent Developments
11.12 Harbin Pharmaceutical Group
11.12.1 Harbin Pharmaceutical Group Corporation Information
11.12.2 Harbin Pharmaceutical Group Overview
11.12.3 Harbin Pharmaceutical Group Lacidipine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Harbin Pharmaceutical Group Lacidipine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Harbin Pharmaceutical Group Recent Developments
11.13 Zhejiang Better Pharmaceuticals
11.13.1 Zhejiang Better Pharmaceuticals Corporation Information
11.13.2 Zhejiang Better Pharmaceuticals Overview
11.13.3 Zhejiang Better Pharmaceuticals Lacidipine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Zhejiang Better Pharmaceuticals Lacidipine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Zhejiang Better Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Lacidipine Industry Chain Analysis
12.2 Lacidipine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Lacidipine Production Mode & Process
12.4 Lacidipine Sales and Marketing
12.4.1 Lacidipine Sales Channels
12.4.2 Lacidipine Distributors
12.5 Lacidipine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Lacidipine Industry Trends
13.2 Lacidipine Market Drivers
13.3 Lacidipine Market Challenges
13.4 Lacidipine Market Restraints
14 Key Findings in The Global Lacidipine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer